Comparative Analysis of Intra-articular Injection of Steroid and/or Sodium Hyaluronate in Adhesive Capsulitis

December 17, 2013 updated by: Hyunchul Jo, Seoul National University Hospital

Comparative Analysis of Intra-articular Injection of Steroid and/or Sodium Hyaluronate in Adhesive Capsulitis: A Randomized, Double-blind, Placebo-controlled Trial

The purpose of this study is to compare the efficacy of intra-articular steroid injection, sodium hyaluronate injection, a combination of the two, and placebo in the treatment of adhesive capsulitis of the shoulder.

Study Overview

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of, 156-707
        • Joint & Spine Center, SMG-SNU Boramae Medical Center, Department of Orthopedic Surgery, Seoul National University College of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • clinical diagnosis : Adhesive Capsulitis of the Shoulder
  • defining of adhesive capsulitis

    • the presence of shoulder pain
    • limitation of both active and passive movements of the glenohumeral joint of ≥25% in at list 2 directions(abduction,flexion,external rotation,internal rotation), as compared with the contralateral shoulder
  • duration : symptomatic for < 1 year

Exclusion Criteria:

  • bilateral symptoms
  • uncontrolled diabetes mellitus
  • overt hypothyroidism or hyperthyroidism
  • previous shoulder surgery
  • previous glenohumeral joint injection within recent 6months
  • trauma to the shoulder the last six months that required hospital care
  • neurological symptoms
  • allergy to injection material
  • secondary adhesive capsulitis
  • systemic inflammatory ds including rheumatoid arthritis
  • degenerative arthritis of shoulder joint
  • infectious arthritis of shoulder joint
  • dislocation of shoulder joint
  • blood coagulation disease
  • rotator cuff tear
  • serious mental illness
  • pregnancy
  • fracture in shoulder lesion
  • CVA

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
PLACEBO_COMPARATOR: Isotonic saline
  • Total volume of injection drugs: 8ml
  • isotonic saline 4ml + telebrix(contrast media) 4ml
  • The number of injections : only once during the study period
  • Injection site : glenohumeral joint
  • Material : 22-gauze spinal needle
  • Anteroposterior, lateral, and axial arthrography after injection was performed to determine accuracy and patterns of the injection.
EXPERIMENTAL: Steroid
  • Total volume of injection drugs: 8ml
  • triamcinolone(40mg)1ml + isotonic saline 3ml + telebrix(contrast media)4ml
  • The number of injections : only once during the study period
  • Injection Site : glenohumeral joint
  • Material : 22-gauze spinal needle
  • Anteroposterior, lateral, and axial arthrography after injection was performed to determine accuracy and patterns of the injection.
EXPERIMENTAL: Hyaluronate
  • Total volume of injection drugs: 8ml
  • sodium hyaluronate 2ml + isotonic saline 2ml + telebrix(contrast media)4ml
  • The number of injections : only once during the study period
  • Injection Site : glenohumeral joint
  • Material : 22-gauze spinal needle
  • Anteroposterior, lateral, and axial arthrography after injection was performed to determine accuracy and patterns of the injection.
EXPERIMENTAL: Steroid + Hyaluronate
  • Total volume of injection drugs: 8ml
  • triamcinolone(40mg)1ml + sodium hyaluronate 2ml + isotonic saline 1ml + telebrix(contrast media)4ml
  • The number of injections : only once during the study period
  • Injection Site : glenohumeral joint
  • Material : 22-gauze spinal needle
  • Anteroposterior, lateral, and axial arthrography after injection was performed to determine accuracy and patterns of the injection.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
SPADI Score (Shoulder Pain and Disability Index)
Time Frame: Postinjection 1month
Postinjection 1month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2010

Primary Completion (ACTUAL)

June 1, 2012

Study Completion (ACTUAL)

December 1, 2013

Study Registration Dates

First Submitted

June 8, 2010

First Submitted That Met QC Criteria

June 14, 2010

First Posted (ESTIMATE)

June 15, 2010

Study Record Updates

Last Update Posted (ESTIMATE)

December 19, 2013

Last Update Submitted That Met QC Criteria

December 17, 2013

Last Verified

December 1, 2013

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adhesive Capsulitis

Clinical Trials on isotonic saline injection into the glenohumeral joint

3
Subscribe